Post-approval studies (Phase 4)Not Yet RecruitingNCT07162090
What this trial is testing
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients
Who this might be right for
SarcopeniaAnemia Associated With Chronic Kidney Disease (CKD)Dialysis Patients
Tianjin Medical University General Hospital 60